SynteractHCR named Frank Santoro, M.D., who has more than 30 years of experience and most recently was Novella Clinical’s CMO, as its CMO.

DNA-encoded library technology expert HitGen just inked a multiyear, multitarget drug discovery deal with Aduro Biotech.

Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.

WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.

Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.

German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.

After months of rumors and amid a larger flurry of CRO M&A activity, LabCorp has bought out U.K. CRO Chiltern.

A BMJ paper has shown that progress is being made on clinical trial transparency, although there is still a way to go.

BeiGene is adding Medidata’s electronic patient-reported outcome solution to oncology clinical studies.